Transcode Therapeutics RNAZ
NASDAQ RNAZ
$1.65 +0.02 (+1.23%)
As of: Sep 30, 2026 · 3:51 PM EDT

Transcode Therapeutics (RNAZ) Share-based Compensation (2020 - 2025)

Updated

Transcode Therapeutics' Share-based Compensation came in at $61,865 for Q4 2025, down 63.3% from $168,770 a year earlier and down 53.9% from the prior quarter.

Analysis

Transcode Therapeutics (RNAZ) Share-based Compensation (2020 - 2025) Analysis & Trends

For FY2025, Transcode Therapeutics' Share-based Compensation was $485,428, down 71.4% from FY2024.

  • Share-based Compensation carries a five-year compound annual growth rate of 60.6% (FY2020 to FY2025).
  • Going back by year, Share-based Compensation was $1.7 million in FY2024 (+64.0%), $1.04 million in FY2023 (+162.3%), $395,329 in FY2022 (+112.5%) and $185,996 in FY2021 (+309.3%).
  • The Q4 2025 figure represents the lowest quarterly Share-based Compensation since Q1 2022.
  • Year-over-year, Share-based Compensation has declined for six consecutive quarters, with growth averaging 34.2% over the last eight quarters.
  • The fastest year-over-year change in Share-based Compensation over five years came in Q2 2024 (growth of 551.7%), and the weakest in Q2 2025 (a decline of 88.5%).
  • Business Quant data shows RNAZ's Share-based Compensation at $134,324 (Q3 2025), $131,510 (Q2 2025) and $157,729 (Q1 2025) in the three quarters before Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 458.00 Mn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 166.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 170.20 Mn
10 Transcode Therapeutics 1.65 Mn 1.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 61,865.00
Sep 30, 2025 134,324.00
Jun 30, 2025 131,510.00
Mar 31, 2025 157,729.00
Dec 31, 2024 168,770.00
Sep 30, 2024 204,482.00
Jun 30, 2024 1.14 Mn
Mar 31, 2024 183,152.00
Dec 31, 2023 310,314.00
Sep 30, 2023 392,331.00
Jun 30, 2023 175,484.00
Mar 31, 2023 158,760.00
Dec 31, 2022 130,555.00
Sep 30, 2022 105,602.00
Jun 30, 2022 98,599.00
Mar 31, 2022 60,573.00
Dec 31, 2021 39,000.00
Sep 30, 2021 64,051.00
Jun 30, 2021 34,514.00
Mar 31, 2021 48,431.00
API Access

Transcode Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RNAZ&period=max&api_key=YOUR_API_KEY